How Lead Exposure Research Connects to Dementia Risk
Decades-old lead exposure may be silently accelerating cognitive decline in aging brains through mechanisms science is only now confirming.
Category Genetics
How Living Alone Changes Alzheimer’s Risk and Safety
Living alone doesn't cause Alzheimer's, but it removes the safety net that catches early warning signs and manages daily risks as dementia progresses.
Could Sex-Specific Biomarkers Improve Diagnosis?
Sex differences in Alzheimer's pathology suggest women and men need different biomarker thresholds for accurate dementia diagnosis.
How Alzheimer’s Risk Differs Between Men and Women
Men and women face different Alzheimer's risks shaped by genetics, menopause, and patterns of cognitive decline.
How Work Complexity Relates to Dementia Risk
Intellectually demanding work might protect your brain or damage it—the difference is whether the job gives you sleep and autonomy.
How Bilingualism Research Connects to Dementia Risk
Speaking two languages throughout life may delay dementia symptoms by 4 to 5 years, even when brain damage is identical.
Can Biomarker Stages Replace Symptom Stages?
Biomarkers reveal Alzheimer pathology years before symptoms emerge, but they measure brain disease differently than symptom stages measure actual daily function and care needs.
Could Blood Biomarkers Help Sort Out Brain Fog Causes?
Blood biomarkers reveal inflammation and blood-brain barrier damage in brain fog, but no single test yet provides a complete diagnosis.
What Anticholinergic Drugs Mean for Memory Risk
Anticholinergic medications, common in older adults, directly interfere with brain chemicals necessary for memory formation and may accelerate cognitive decline.
Can Genetic Testing Help Families With Early-Onset Alzheimer’s?
Genetic testing can identify which families carry inherited Alzheimer's mutations, guiding medical surveillance and access to preventive research studies.